MEDLIVE (02192) announced its results for the six months ended June 30, 2025. The group achieved revenue of 312 million yuan during the period, representing a year-over-year increase of 28.2%. Profit attributable to owners of the parent company reached 155 million yuan, up 5.9% compared to the same period last year. Basic earnings per share were 21.2 cents.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.